Multiplexed same type-antigenic peptide
US10428112B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2015 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Nov 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a synthetic peptide capable of inducing an antibody to an autoantigen, and specifically, provides: a multiplexed same type-antigenic peptide having a dendritic core and B-cell recognition peptides, wherein the multiplexed same type-antigenic peptide comprises 4 to 8 B-cell recognition peptides of the same type that are bound to the terminal ends of the dendritic core directly or via a spacer, and each B-cell recognition peptide is bound to the terminal end of the dendritic core directly or via a spacer; an antibody production-inducing agent having the peptides; and a method for producing the peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.